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Summary
Generalized case-cohort design has been proposed to assess the effects of exposures on survival 
outcomes when measuring exposures is expensive and events are not rare in the cohort. In such 
design, expensive exposure information is collected from both a (stratified) randomly selected 
subcohort and a subset of individuals with events. In this paper, we consider extension of such 
design to study multiple types of survival events by selecting a proportion of cases for each type of 
event. We propose a general weighting scheme to analyze data. Furthermore, we examine the 
optimal choice of weights and show that this optimal weighting yields much improved efficiency 
gain both asymptotically and in simulation studies. Finally, we apply our proposed methods to data 
from the Atherosclerosis Risk in Communities study.
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1. Introduction
Case-cohort study design is an economical means for large cohort studies with rare survival 
events when it is expensive to assemble covariate information for all cohort members 
(Prentice, 1986). In such design, a random sample from the full cohort, namely subcohort, is 
selected via simple random sampling, then all subjects having events of interest outside this 
subcohort are sampled. The covariate information on the expensive exposure is obtained for 
the subcohort members as well as all sampled cases.
Extensive work has been done for the case-cohort studies with a single event. Prentice 
(1986) and Self and Prentice (1988) proposed a pseudo-likelihood approach for inference. In 
order to improve efficiency, Barlow (1994) developed a robust estimator using a time-
varying weight. Later, Borgan et al. (2000) considered the subcohort selected via a stratified 
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random sampling and showed that the stratification leads to more powerful and efficient 
estimators than the unstratified case-cohort study. Kulich and Lin (2004) and Samuelsen et 
al. (2007) proposed efficient estimation for a stratified case-cohort design by using auxiliary 
covariate data.
In many applications, the same subject can experience multiple types of survival events. 
When these survival outcomes are all of interest, the case-cohort design has also been 
recommended to study the effects of risk factors on multiple diseases simultaneously, where 
the information on expensive exposures from a subcohort and the cases of all event types is 
collected. Using data from this design, Kang and Cai (2009; 2010) developed estimation 
procedures based on the joint analysis in the unstratified and stratified case-cohort studies, 
respectively. However, when one particular event is of interest, their methods did not use all 
available exposure information collected on the cases of the other types of events. More 
recently, Kim et al. (2013) proposed estimating equations with a new weight function to 
incorporate this information in order to improve efficiency for estimation.
All the aforementioned methods considered the classical case-cohort study design, which 
samples all event cases for exposure assessment. However, in many cohort studies, the 
number of cases can be large, because the event is relatively common, the cohort size is 
large, or the follow-up duration is long. For example, in the Atherosclerosis Risk in 
Communities (ARIC) study (Duncan et al., 2003; Ballantyne et al., 2004), 15,792 subjects 
were recruited from 1987 to 1989 and followed up since then. It was of interest to examine 
the effect of high-sensitivity C-reactive protein (hs-CRP) on incident diabetes events. In the 
ARIC study, the rate of diabetes is 11.2%, resulting in a large number of cases. Since 
measuring hs-CRP from blood sample was expensive at the time, it was not feasible to 
measure the expensive covariates from all cases due to limited resources.
When there are a large number of cases, instead of collecting exposure information from all 
cases, a generalized case-cohort design was proposed where only a fraction of the non-
subcohort cases were sampled for exposure assessment. Cai and Zeng (2007) provided 
sample size and power calculation for this generalized case-cohort design. They 
demonstrated that when the event was not rare, such a design could perform as well as a 
classical case-cohort design even if a small fraction of the cases were sampled. Kim et al. 
(2016) extended Kim et al. (2013)’s classical case-cohort design to generalized case-cohort 
design for additive hazard models but they considered only two disease. In this paper, we 
extend the idea of the generalized case-cohort design to study multiple survival events. 
Specifically, in addition to a randomly chosen subcohort, a subsample of each type of event 
cases is selected to assemble expensive covariate information. The sampling fractions may 
differ for different event types. Furthermore, we allow stratified sampling in this design 
which is typical in biomedical research. The strata are usually formed based on participants’ 
characterisitics at baseline and sampling probabilities may vary across different strata in 
order to oversample low-prevalence subpopulations for study purpose. We then develop an 
efficient approach to analyze data arising from such design. Particularly, we propose a 
general weighting scheme to account for the fact that only fractions of the cases are sampled 
in this generalized case-cohort design. The proposed general weighting includes the weights 
in Kim et al. (2013) as a special case.
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The paper is organized as following. In Section 2, we describe models, estimation 
procedures, and their asymptotic properties for the proposed methods. Section 3 provides 
optimally weighted estimators and Section 4 reports simulation results. In Section 5, we 
apply our proposed method to data from the Atherosclerosis Risk in Communities (ARIC) 
study. Some concluding remarks are given in Section 6.
2. Generalized Case-Cohort Design for Multiple Events
Suppose that there are n independent subjects and K survival endpoints of interest in a 
cohort. In order to ensure proper representation of certain subgroups in the sampling of the 
subcohort, the entire cohort can be divided into mutually exclusive strata. These strata are 
usually defined by participants’s baseline characteristics. Assume that there are L strata. Let 
Tlik be the failure time, Clik be the potential censoring time, and Zlik(t) be a p × 1 possibly 
time-dependent covariates vector for disease k of subject i in stratum l, l = 1, …, L, k = 1, 
…, K, i = 1, …, nl, where nl is defined as the number of subjects in stratum l. Let Xlik = 
min(Tlik, Clik) denote the observed time of type k in the full cohort and Δlik = I(Tlik ≤ Clik) 
be the indicator for event k. We use Vlik to denote the stratum that the participant belongs to. 
In order to study the effects of covariates on each type of events, we consider the event-
specific hazards model: for disease k of subject i in stratum l, the hazard function λlik(.) 
associated with Zlik(t) is assumed to be




where λ0k(t) is a baseline hazard function and βk is a p-vector unknown parameter for 
disease k. Note that Vlik can be part of Zlik if it is of interest to adjust for the sampling strata 
for the exposure effect. Finally, we assume that Tlik is independent of Clik given Zlik.
2.1 Generalized case-cohort design
In generalized case-cohort design, we select a fixed size ñl subjects from nl subjects in 
stratum l into the subcohort by using simple random sampling without replacement. After 
sampling the subcohort, another stratified random samples of cases outside of the subcohort 
for each disease outcome are drawn. For disease k in stratum l, we select m∼lk cases outside of 
the subcohort using simple random sampling without replacement. Let ξli indicate whether 
subject i in stratum l is selected into the subcohort and ηlik be the sampling indicator of 
selecting case of type k outside the subcohort in stratum l. Note that for k ≠ k′, (ηl1k, …, ηlnlk
)
is independent of (ηl1k′, …, ηlnlk′
) conditional on disease status. But the elements in 
(ηl1k, …, ηlnlk
) are correlated because of the sampling scheme.
Let Zlik(t) = Zlik
E (t), Zlik
C (t)  where Zlik
E (t) represents the expensive covariates that are only 
available on subjects who are in the case-cohort sample, while Zlik
C (t) denotes the covariates 
information that are available on the entire sample, for example, age and sex. In the 
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generalized case-cohort design, the actual data for subject i consist of 
Xlik, Δlik, Zlik
E (t), Zlik
C (t), 0 ≤ t ≤ Xlik  when ξli = 1 or ηlik = 1 and Xlik, Δlik, Zlik
C (t)  when ξli = 
0 and ηlik = 0 (k = 1, …, K). Let τ denote the end of study time.
2.2 A class of weighted estimating equations
Let Nlik(t) = I(Xlik ≤ t, Δlik = 1) be the counting process for the observed failure time and 
Ylik(t) = I(Xlik ⩾ t) denote the at-risk indicator for disease k of subject i in stratum l, where 
I(.) is the indicator function. Let n = ∑l = 1L nl be the total size of the cohort, n = ∑l = 1L n∼l be 
the total size of the subcohort, dlk and d
∼
lk denote the numbers of subjects with disease k in 





Pr(ηlik = 1|Δlik = 1, ξli = 0) = m
∼
lk /(dlk − d
∼
lk), denoted by γ
∼
lk. The first probability is the 
selection probability of subjects for the subcohort and the second probability is the selection 
probability of subjects outside the subcohort with disease k in stratum l.
When exposure information is available for all subjects, estimating function based on the 




















TZlik(t) for d = 0, 1 and 2. Under 
generalized case-cohort design, the expensive exposure information is available only for 
subjects in the subcohort as well as sampled subjects with diseases of interest. Therefore, to 
use the data from this design for inference, our key idea is to use the subjects with available 
expensive exposure information to approximate each component on the right-hand side of 




























TZlik(t) for d = 0, 1 and 2. Here, 
πlik(t) is a non-negative weight function that depends on ξli and ηlik’s such that πlik(t) = 0 if 
ξli = 0 and ηlik = 0 for any k (i.e. subject i’s expensive exposure information is not available, 
and E[πlik(t)] = 1. For any such weight πlik’s, we solve U
∼
k
O(β) = 0 and denote its solution as 
βk. Additionally, with the estimators for βk’s, we can estimate the cumulative baseline 
hazard functions using the Breslow-Aalen type estimators given by
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To construct the weight function πlik(t), we partition the whole cohort into disjoint parts, 
where each part consists of subjects who experience some events but not the others within 
each stratum, i.e.,




(1 − Δliq) = 1 , l = 1, …, L, and v = 1, …, 2
K − 1
where Dlv is the v-th nonempty subset of S = {1, …, K} and Dlv is the complementary set of 
Dlv. We also use 𝒞l0 to denote the set of subjects with no event, i.e., 
𝒞l0 = i: ∏ j = 1K (1 − Δlij) = 1 . Thus, in the generalized case-cohort design, subject i in 𝒞l0
can only be selected if the subject is in the subcohort (ξli = 1). For subject i in 𝒞lv for v ⩾ 1, 
the subject can be selected either because the subject is in the subcohort (ξli = 1) or because 
the subject is selected in the cases outside the subcohort (ξli = 0 but some ηlij = 1 where j 
indicates an event in 𝒞lv). Note that for the latter, subject i may be selected due to more than 
one event. Our proposed method is to assign different weights to subjects in each such 













I(i ∈ 𝒞lv)(1 − ξli) ∑









where the last summation sums over all nonempty subset of Dlv, Dlv/D denotes the set of 
indices in Dlv but not in D, and ã0lk(t), ãvlk(t),and b
∼
D, lk(t) are chosen to ensure E[πlik(t)] = 1, 
for instance, the inverse probabilities of being sampled in each partitioned set.
To better illustrate the proposed approach, we use K = 2 as one example. Suppose there are 
two diseases of interest: diabetes and coronary heart disease (CHD). We can decompose the 
whole cohort into four groups within each stratum: Subjects a) with no disease, b) with only 
diabetes, c) with only CHD, and d) with both diabetes and CHD. Within each group that has 
at least one event, subjects are further divided into two subgroups: 1) those cases in the 
subcohort and 2) those cases who are outside the subcohort. These case subgroups and the 
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group with no events form the 9 partitioned disjoint sets. In this situation, the proposed 
weight is
πlik(t) = (1 − Δli1)(1 − Δli2)ξlia
∼
0lk(t)
+ Δli1(1 − Δli2) ξlia
∼
1lk(t) + (1 − ξli)ηli1b
∼
1lk(t)
+ (1 − Δli1)Δli2 ξlia
∼













where without confusion, we re-index b
∼




5lk(t). Figure 1 illustrates all 
these partitions and the corresponding weights.
Note that the disjoint parts are defined within each stratum in order to calculate the proper 
weights. The strata are disjoint, so if two subjects belong to two strata, they will be in two 
separate disjoint parts.
Remark 1—The weights in (3) can be time-independent or time-varying. Prentice (1986) 
originally proposed constant weights. To improve efficiency, time-varying weights have been 
proposed by considering only subjects at risk at time t, not all subjects in the original cohort 
(Barlow, 1994; Borgan et al., 2000). The proportion of those at risk in the subcohort out of 
all those at risk in the entire cohort could be different at different time point. A time-varying 
weight function is more general than a time-constant weight function and it is shown that it 
produces better estimator (e.g. (Borgan et al., 2000)).
Remark 2—Our proposed method is equivalent to viewing type k′ cases as non-cases 
when considering failure type k. However, even for those type k′ cases, the probabilities of 
being selected for collecting expensive exposure information can be different for different k′ 
in a generalized case-cohort design. Therefore, different weight functions may be necessary 
for those “non-cases”. The proposed class of the general weighted functions guarantees 
consistent estimation once the weights satisfy the condition E[πlik(t)]=1, as shown in 
Theorem 1.
Remark 3—In the estimating function for a particular disease k, Kang and Cai (2010)’s 
weight function ignores the covariate information collected on subjects who have other types 
of diseases and only uses individuals in the subcohort plus those sampled individuals with 
disease k for their weight function. Kim et al. (2016) in addition uses individuals with the 
other type of disease in their weight function in the set up when two diseases are considered. 
The basic idea for Kim et al. (2016)’s weight function is to divide the cohort into various 
strata defined by the status of the two diseases of interest. Then Kim et al. (2016)’s weight 
function is calculated within each of these strata by the inverse of the proportion of those 
who are at risk and are sampled among those who are at risk. Note that Kim et al. (2016)’s 
weight functions used only covariate information on subjects with the other disease, not the 
information on the disease status. Both existing weight functions proposed by Kang and Cai 
(2010) and Kim et al. (2016) are special cases of our proposed weight function (3). In 
particular, for Kang and Cai (2010)’s method, the weights used for disease k correspond to
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nl (1 − Δlik)Ylik(t)
∑i = 1







nl Δlik(1 − ξli)Ylik(t)
∑i = 1








while the weights proposed by Kim et al. (2016) correspond to
a∼0lk(t) =
∑i = 1n Ylik(t)∏ j = 12 (1 − Δlij)
∑i = 1n Ylik(t)∏ j = 12 (1 − Δlij)ξli








∑i = 1n Ylik(t)Δli1(1 − Δli2)
∑i = 1n Ylik(t)Δli1(1 − Δli2)ηli1
, b∼2lk(t) =
∑i = 1n Ylik(t)(1 − Δli1)Δli2





4lk(t) = − b
∼
5lk(t) =
∑i = 1n Ylik(t)Δli1Δli2
∑i = 1n Ylik(t)Δli1Δli2(ηli1 + ηli2 − ηli1ηli2)
.
Furthermore, when all cases outside the subcohort are selected (i.e. ηli1 = ηli2 = 1), the 
weight functions in (3) reduce to ϕlik(t) = ∏ j = 1K (1 − Δlij)ξliα∼lk−1(t) + 1 − ∏ j = 1K (1 − Δlij) , 
which was proposed by Kim et al. (2013) for the traditional case-cohort design.
2.3 Asymptotic properties
In this section, we provide the asymptotic properties for the proposed method for the 
generalized case-cohort studies. Let
Qlik(β) = ∫0
τ




lk(t) + (1 − ξli) ∑





(1 − ηlij) b
∼
D, lk(t)],
Rlik(β, t) = Ylik(t)[Zlik(t) − ek(β, t)]e
βTZlik(t)
R∼lik(β, t) = Rlik(β, t) −
Ylik(t)El ∏ j = 1K (1 − Δi1 j)Rl1k(β, t)




(β) = Qlik(β) − ∫0
τ Ylik(t)El dQl1k(β, t) |𝒞lv
El Yl1k(t) |𝒞lv
.
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Theorem 1—Under the regularity conditions in the Supplementary material (Web 
Appendix A) and assuming nl/n → ql and α∼l αl for l = 1, …, L, βk converges in 
probability to βk and n1/2(βk − βk) is asymptotically normally distributed with mean zero and 










VII, lk(β) + VIII, lk(β)],
VI, lk(β) = E[Ql1k(β)]
⊗ 2,
VII, lk(β) = Var[ ∏
j = 1
K
(1 − Δl1 j)∫0
τ
R∼lik(β, t)dΛ0k(t)],






− 1 Var Q∼l1k, 𝒞lv
(β) |𝒞lv .
From Theorem 1, we note that Σk(β) consists of three parts. The first part VI,lk(β) is a 
contribution to the variance from the full cohort, and the second part VII,lk(β) and the third 
part VIII,lk(β) are due to sampling for the subcohort and for a portion of cases in non-
subcohort, respectively. For studies based on the entire cohort, the second and third parts 
vanish, so the variance contains only the first part VI,lk(β). If traditional stratified case-
cohort studies are conducted, then the third part equal to 0. Moreover, for unstratified 
generalized case-cohort studies (i.e. L = 1 and ql = 1), the variance only consists of VI,1k(β), 
VII,1k(β), and VIII,1k(β). The illustration of asymptotic covariance when K = 2 has been 
added in Supplementary material (Web Appendix C).
For the asymptotic property of the baseline cumulative hazard function estimators Λ
∼
0k(βk, t)
we define D[0, τ] be a metric space consisting of right-continuous functions f(t) with left-
hand limits, where f(t) : [0, τ] → R and d(f, g) = supt∈[0,τ]{|f(t) − g(t)|} for f, g ∈ D[0, τ]. 
The properties are summarized in the following theorem.
Theorem 2—Under the regularity conditions in the Supplementary material (Web 
Appendix A), Λ
∼
0k(βk, t) is a consistent estimator of Λ0k(t) in t ∈ [0, τ] and 
n1/2 Λ∼0k(t) − Λ0k(t)  converges weakly to a mean zero Gaussian process in D[0, τ] whose 
covariance function is given in the Supplementary material (Web Appendix A).
The proofs for Theorems 1 and 2 are provided in the Supplementary material (Web 
Appendix A).
3. Optimal Weighted Estimator
We aim to derive the optimal estimator among the class of generalized weighted estimating 
functions in Section 2.2. Equivalently, we wish to find the optimal weight for πlik(t) such 
that the asymptotic variance for each βk is minimized.
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From the expression in Theorem 1, the sandwich covariance matrix for βk depends on the 
first derivative of the weighted estimating functions Ak(βk) and the asymptotic variance of 




so is independent of the weights. Thus, only the asymptotic variance of the proposed 
weighted estimating functions Var U∼k
O(β)  depends on the choice of weights. In order to find 
the optimal weights in the proposed weight function, we should minimize Var U∼k
O(β) . Since 
this variance depends on the joint distribution of all outcomes in a complicated way, in the 
Supplementary material (Web Appendix B), we assume the weights at each partitioned 
region to be approximately constant yielding that the choice of πlik(t)’s with the smallest 
variance subject to constraint E{πlik(t)} = 1 is optimal.
For illustration, we consider K = 2. After some algebra, this optimization is equivalent to 
minimizing
E ∏ j = 12 (1 − Δlij) αlk(t)a∼l0k2 (t)
+ E Δli1(1 − Δli2) αlk(t)a
∼
1lk




+ E Δli1Δli2 [αlk(t)a
∼
3lk
2 (t) + (1 − αlk(t))(γl1(t)b
∼
3lk



















1 = E ∏ j = 12 (1 − Δlij) αlk(t)α0lk(t)
+ E Δli1(1 − Δli2) αlk(t)α
∼
1lk(t) + (1 − αlk(t))γl1(t)b
∼
1lk(t)
+ E (1 − Δli1)Δli2 αlk(t)α
∼
2lk(t) + (1 − αlk(t))γl2(t)b
∼
2lk(t)
+ E Δli1Δli2 [αlk(t)α
∼
3lk(t)







Using the Lagrange multiplier (the detail is given in the Supplementary material (Web 
Appendix B)), we obtain the optimal weights as
a∼0lk(t) = αlk(t)
−1, a∼1lk(t) = b
∼










4lk(t) = − b
∼
5lk(t)
= [αlk(t) + 1 − αlk(t) γl1(t) + γl2(t) − γl1(t)γl2(t) ]
−1 .
(5)
In other words, this proposed weight yields the smallest asymptotic variance. Using the 
observed data, the optimal weights can be estimated as
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nl Ylik(t)(1 − Δlik)ξli
∑i = 1




nl Ylik(t)Δli1(1 − ξli)ηli1
∑i = 1





nl Ylik(t)Δli2(1 − ξli)ηli2
∑i = 1
nl Ylik(t)Δli2(1 − ξli)
, a0lk
^ (t) = αlk
^ (t)−1
α1lk
^ (t) = b1lk
^ (t) = [αlk
^ (t) + 1 − αlk
^ (t) γl1
^ (t)]−1, a2lk
^ (t) = b2lk
^ (t) = [αlk




^ (t) = b3lk
^ (t) = b4lk
^ (t) = − b5lk
^ (t) = [αlk
^ (t) + 1 − αlk
^ (t) γl1
^ (t) + γl2
^ (t) − γl1
^ (t)γl2
^ (t) ]−1 .
If all information of covariates are available, all the sampling probabilities and the weights 
are equal to 1 (i . e . αlk^ (t) = γlk̂(t) = 1 for k = 1, …, K). Consequently, the optimal weighting 
function is the Cox score function in this extreme case.
4. Simulation Study
We conduct simulation studies to investigate the finite sample properties of the proposed 
methods. We also compare it with Kang and Cai (2010)’s and Kim et al. (2016)’s weights, 
and compare the performance of stratified sampling with unstratified sampling. Kang and 
Cai (2010)’s method ignores the exposure information of subjects with other disease, so we 
consider the results based on Kang and Cai (2010) as naïve analysis for comparison.
In the simulation study, we consider K = 2 and generate multivariate failure time data from 
Clayton-Cuzick model (Clayton and Cuzick (1985)). The bivariate survival function for the 
bivariate survival time (T1, T2) given (Zl1, Zl2) has the following form:
F(t1, t2 |Zl1, Zl2) = S1(t1; Zl1)
−1/θ + S2(t2; Zl2)
−1/θ − 1 −θ,
where Zl1 = Zl2 = Z is generated from Bernoulli distribution with pr(Z = 1) = 0.5, 





, λ0k(t) and βk (k = 1, 2) are the baseline 
hazard function and the covariate effect for disease k, respectively, and θ is the association 
parameter between the failure times of the two diseases. Exponential distribution with failure 
rate λ0ke
βkZlk is considered for the marginal distribution of Tk (k = 1, 2). The relationship 
between Kendall’s tau, τθ, and θ is τθ = 1/(2θ + 1), smaller Kendall’s tau represents a less 
correlation between T1 and T2. Values of 0.1, 0.67 and 4 are used for θ so the corresponding 
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Kendall’s tau is 0.83, 0.43 and 0.11, respectively. We set βk = 0 or log2, λ01 = 2 and λ02 = 
4. Additionally, we generate sampling strata variable V where V has two strata: 0 and 1. We 
define two parameters: η =Pr(V = 1|Z = 1) and ν =Pr(V = 0|Z = 0). Hence, an unstratified 
sampling is a special case with η = 0.5 and ν = 0.5. The larger the values of η and ν than 0.5 
the more V and Z are correlated. For stratified case-cohort studies, we set the values [η, ν] = 
[0.7, 0.7] and [η, ν] = [0.9, 0.9]. Finally, the censoring time is simulated from uniform 
distribution [0, u] where u depends on the specified level of the censoring probability 
resulting in the event rate of 10% and 12% for k = 1 and 18% and 23% for k = 2. Overall, 
the proportions of subjects who have both diseases are around 8%, 5% and 3% for θ = 0.1, 
0.67 and 4, respectively. The sample size of the full cohort is set to be n = 4000. For the 
generalized case-cohort design, we select the subcohort and a subset of cases by simple 
random sampling as well as stratified sampling and consider the subcohort size of 400 and 
800. We select the subcohort ñl = ñ × ql from each stratum. By using a simple random 
sampling, we select non-subcohort cases size of m∼lk = (dlk − d
∼
lk) × γk for k = 1, 2 and l = 0, 
1. For each configuration, 2000 replications are conducted.
In the first set of simulations, we consider generalized case-cohort studies with simple 
random sampling of subcohort and cases (i.e. L = 1). Our main interests are to estimate the 
effect of Z on disease 1 (β1) but covariate information for disease 2 is available from another 
generalized case-cohort study. We examine the performance of our proposed estimator based 
on (2) with optimal weights (5) which uses the additional information collected on the 
sampled subjects with disease 2. We set the selection probabilities of cases outside the 
subcohort for disease 1 and 2 with 0.1 and 0.2. Table 1 summarizes the results. For different 
combinations of true β1, case selection probabilities, the subcohort sample size, and 
correlation between two failure times, Table 1 shows the average of the estimates for β1, the 
average of the proposed estimated standard error (SE), empirical standard deviation (SD), 
and sample relative efficiency (SRE). The subscripts for SE, SD, and CR refer to the 
proposed method (o), Kim et al. (2016)’s method (k), and Kang and Cai (2009)’s method 
(c). The sample relative efficiency (SRE) relative to Kim et al. (2016)’s method and Kang 
and Cai (2009)’s method are defined as, SRE1 = SDk
2/SDo
2 and SRE2 = SDc
2/SDo
2, respectively.
From the results, we observe that the three estimators are approximately unbiased. The 
average of the proposed estimated standard error is close to the empirical standard deviation. 
As expected, larger case selection probability and subcohort size produce smaller standard 
deviations. The range of the 95% confidence interval coverage rate for the proposed optimal 
weight is between 94%-96%. All sample relative efficiency, defined as squared empirical 
standard deviations of the existing weight relative to those of the proposed optimal weight, 
are greater than 1. The results in Table 1 show that our proposed optimal weights are the 
most efficient compared to the other two weights. Specifically, the optimal weight increases 
the efficiency from 15% to 172% with higher efficiency gain associated with smaller case 
selection probability and larger subcohort size. Furthermore, the efficiency gain is larger 
when the dependence between the disease outcomes are more correlated.
In the second set of simulations, we also examine the performance for the proposed optimal 
weight under stratified case-cohort design and compare it with Kang and Cai (2010)’s and 
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Kim et al. (2016)’s weights. The population and subcohort sizes are 2000 and 400, 
respectively. We set the event proportion for disease 1 and disease 2 [12%, 23%] and case 
selection probabilities [0.3, 0.6]. Table 2 provides summary statistics for the estimate of β1 = 
0 and log(2). The conclusions are similar with those in Table 1. Note that empirical standard 
deviations are smaller when the correlation between stratum variables and covariates is 
larger. It suggests that stratified sampling produces efficiency gain when stratum variable is 
associated with covariate.
When there are more studies with other types of diseases, the number of subjects with 
expensive exposure information increases. Therefore, using information from more studies 
with other types of diseases could improve efficiency. We conducted some additional 
simulations including 3 diseases types. The results are summarized in the Supplementary 
material (Web Appendix D: Table S1). We compared the performance of the estimators for 4 
different weights: 1) optimal weights with 3 disease types, 2) optimal weights with 2 disease 
types, 3) Kim et al. (2016)’s weight with 2 disease types, and 4) Kang and Cai (2010)’s 
weight with 2 disease types. The results suggest that the optimal weight with 3 disease types 
improved efficiency. We also provide information on computing time in the Supplementary 
material (Web Appendix D: Table S2). Computation time for using the optimal weight with 
3 disease types is about 1.7 times of that for using the optimal weight with 2 disease types 
and the Kim et al. (2016)’s weight and it is about 3 times of that for using the Kang and Cai 
(2010)’s weight.
5. Application to the ARIC Study
We apply the proposed method to a data set from the ARIC study which is a population-
based cohort study (Duncan et al., 2003; Ballantyne et al., 2004). This study consists of 
15,792 men and women 45 - 64 years of age from four U.S. communities recruited during 
1987 to 1989. All subjects are followed for incident diabetes. The incident diabetes are 
defined as a reported physician diagnosis, use of antidiabetes medications, a fasting (⩾ 8 
hours) glucose ⩾ 7.0 mmol/l, or a nonfasting glucose of ⩾ 11.1 mmol/l. Subjects are 
regarded as censored if they are alive and event-free at the end of 1998 or lost to follow-up.
Our interest is to investigate the association between high-sensitivity C-reactive protein (hs-
CRP), which is a biomarker of inflammation, and incident diabetes events. In order to 
measure hs-CRP, a case-cohort study was conducted to reduce the cost and save blood 
specimen. Hs-CRP is also available on subjects for incident coronary heart disease (CHD) 
from another case-cohort study in the ARIC study (Ballantyne et al., 2004). We exclude 
subjects with prevalent CHD and prevalent diabetes at baseline, had transient ischemic 
attack or stroke, had missing follow-up visits, were in minority race group except for 
African-American or white, had no valid diabetes determination at follow-ups, or had 
missing CHD information and baseline measurements. The full cohort after exclusion 
consists of 10,279 subjects.
To preserve frozen biologic specimens and reduce costs, a generalized case-cohort design is 
conducted by selecting a subset of incident diabetes events since the rate of diabetes during 
follow-up is 11.2%. The subcohort and cases of incident diabetes are randomly selected via 
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stratified sampling where the strata variables are age at baseline (≤ 55 and > 55), sex, and 
race (black and white). Age, gender, race, parental history of diabetes, hypertension, and 
center are confounding factors and are adjusted in the model. The risk factor, hs-CRP, is 
used as a categorical variables with 4 levels based on quartiles. In Table 3, hs-CRP (C2), hs-
CRP (C3), and hs-CRP (C4) are indicator variables for hs-CRP values in the second, third, 
and fourth quartiles, respectively. The hs-CRP values in the first quartile is used as the 
reference group in our analysis.
By using available hs-CRP information collected from both case-cohort studies, we apply 
our proposed method to this data set. The total sample size was 1,576 subjects including 572 
noncases, 581 diabetes cases, 423 CHD cases. The subcohort size is 668 which consists of 
96 diabetes cases and 572 non-cases. To study the effect of hs-CRP on diabetes, we fit the 
model using (1) and compare our proposed optimal estimator with that in Kang and Cai 
(2010) and Kim et al. (2016).
Table 3 presents the estimates, standard errors, hazard ratios, and the 95% confidence 
intervals for the three methods. First, we test overall effects for hs-CRP using our proposed 
method and they are statistically significant. The hazard ratio comparing the fourth with the 
first hs-CRP quartile group is 2.74 and confidence interval indicates that it is of statistical 
significance. Moreover, the hazard ratio comparing the third with the first hs-CRP quartile 
group is also statistically significant, but the hazard ratio for the second versus the first 
quartile group is not statistically significant. Race effect is statistically significant using the 
proposed method while it is not using Kang and Cai (2010)’s and Kim et al. (2016)’s 
methods. The regression coefficient estimates for the proposed method are similar with those 
for the existing method, but all the standard errors are smaller than those of the existing 
method and consequently the 95% confidence intervals are narrower.
6. Concluding Remarks
When multiple generalized case-cohort studies are conducted, some additional information 
for expensive covariates are available. In this paper, we proposed a more general approach 
for the generalized case-cohort study by using this additional information. Our proposed 
estimators are shown to be consistent and asymptotically normally distributed under some 
regularity conditions. We also examined the optimal choice of the weights within our 
proposed class of weights. In addition to simple random sampling for the subcohort and 
cases, we also considered stratified sampling to improve efficiency. The simulation results 
showed that our proposed optimal methods improve efficiency significantly compared to the 
existing methods especially in the situation when the case selection probability is very small.
In this paper, we allow for stratified sampling for the subcohort and cases selection. The 
sampling strata are formed to ensure proper representation of certain subgroups in the 
subcohort. Such stratified sampling will improve the estimation of stratum specific 
quantities if the stratum is relatively small in the whole cohort. It could also improve the 
overall estimation for the primary quantity of interest but that could depend on many factors 
such as the relationship between the strata and the disease of interest, the relationship 
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between the strata and the main exposure as well as other covariates in the model, the 
proportion of each stratum in the cohort, etc.
The model we considered in this paper has the baseline hazard function to be common 
across sampling strata. The effect of the sampling strata can be adjusted for by including the 
sampling strata variable as part of the covariates. This type of model is commonly used in 
epidemiological studies. An extension of this model is to allow the baseline function to be 
different across strata which is also commonly used in biomedical research. It is of interest 
to extend our approach to such stratified model.
The current method assumed the disease-specific effect model as was considered in Wei et 
al. (1989). If part of the covariate effects are expected to be common for different disease 
types, the model considered in Kang and Cai (2009) can be used. Under Kang and Cai 
(2009)’s model, one possibility to improve efficiency is to jointly model all the disease 
outcomes. Incorporating correlation between event times could further improve efficiency as 
was explored in Cai and Prentice (1995). This is worthy of future research.
In this paper, we only consider the situation where the diseases are non-competing and non-
recurrent, for example, as in the situation for the ARIC study where coronary heart disease 
and diabetes are of interest and a person can have both coronary heart disease and diabetes. 
The ideas in this paper can be extend to other setting such as competing risks, semi-
competing risks, or recurrent events. These extensions are worthy of future investigation.
In some applications, proportional hazard assumptions may not be appropriate or 
investigators may be interested in a different form of association between risk factor and 
disease outcomes. Hence, alternatives to proportional hazard models such as additive 
hazards models, proportional odds model, accelerated failure time model, and 
semiparametric transformation model could be of interest. Extending our approaches to such 
models warrants further investigation.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Example of generalized case-cohort data
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